Targeted Cancer Therapy Market: Analysis by Disease Indication (Colorectal Cancer, Breast Cancer, Gastrointestinal, Lung Cancer, Others); Therapy Type (Signal Transduction Inhibitors, Monoclonal Antibodies, Small Molecule Inhibitors, Hormone Therapies, others); End-User (Cancer and Radiation Therapy Centers, Hospitals, Clinics), Region—Market Size, Industry Dynamics, Opportunity Analysis and Forecast for 2026–2035
Targeted cancer therapy market size was valued at USD 90.89 billion in 2025 and is projected to hit the market valuation of USD 175.48 billion by 2035 at a CAGR of 6.80% during the forecast period 2026–2035. Read More
We Are Trusted By These Great Companies!
Last Updated: 01-Feb-2026 | Format: | Report ID: AA02261698